The call, on record
HIMS bullish call
Quoted text as recorded“They might need to do that for the next decade because if they can grow 30 plus percent and compound that over the next decade, this is going to be a huge winner for investors.”@ 13:24 · open at this moment on YouTube ↗
Our interpretation
- Source published
- Jun 29, 2026
- Timeframe
- over the next decade, if the company can compound growth above 30%
- Interpreted confidence
- medium
- Specificity
- vague
Email me when HIMS calls resolve
When a tracked HIMS call is scored — hit, miss or partial — we’ll email you the result. No account needed.
Used only for these updates. Privacy
Our summary of the thesis
Strongly BullishStructured interpretation of the video, not a verbatim quotation. Check the source for conditions, emphasis and context.
The host views Hims & Hers, his largest holding, as an emerging consumer healthcare platform with substantial investor upside if it compounds growth over a decade. Subscriber expansion, additional treatments and international acquisitions underpin the opportunity.
Key arguments
- The platform aggregates healthcare demand and reaches consumers directly.
- Additional treatments and branded GLP-1 products could increase revenue per subscriber.
- Acquisitions expand international reach and the subscriber base.
- The host sees approximately 3.5 times sales as compelling relative to growth.
- He believes the company can prioritize growth now and demonstrate stronger profitability later.
Counter-arguments acknowledged
- Growth has decelerated and was nearly flat in the latest quarter discussed.
- GLP-1 business fluctuations create uneven growth.
- Recent investment has reduced profitability.
- The investment outcome depends on sustained growth.
Hedges and caveats (from the video)
- Tenfold upside is presented as potential, not a guaranteed return.
- SoFi and TransMedics are volatile stocks.
- Hims & Hers has experienced slowing growth and reduced profitability while investing in expansion.
- Toast faces a difficult restaurant industry environment.
- The host does not yet own Toast or TransMedics in the Asymmetric Portfolio.
- TransMedics growth and operating leverage have recently softened.
About this record
Not yet reviewed by a moderatorImported analysis · scheduled AI source. A quote, summary and outcome each need their own context. Moderator review does not certify investment performance.
- Source published
- Jun 29, 2026, 1:57 PM UTC
- First recorded by TubeRank
- Nov 1, 2026, 4:27 AM UTC
- Record last updated
- Nov 1, 2026, 4:27 AM UTC
- Moderator review recorded
- Not recorded
- Transcript provenance
- YouTube captions (manual or automatic)
- Recorded analysis processor/source label
- codex-cli-scheduled
- This can identify a workflow rather than an exact AI model version.
- Submission path version
- manual_v1
- Identifies the precomputed submission path. It does not identify an AI model version or imply human authorship.
- Outcome methodology version
- Not recorded; not audited under current rules
Recent record changes 1 shown
Nov 1, 2026, 4:27 AM UTC
source updated
- Recorded analysis processor/source label
BeforeNot recorded
Aftercodex-cli-scheduled
- Extraction or submission version
BeforeNot recorded
Aftermanual_v1
Showing up to 20 recent changes. The complete feed has 2 recorded events for this call, including its initial entry. Read the full paginated history (JSON); follow nextCursor while hasMore is true.
Stored outcome evidence
- Stored reference price
- Not recorded
- Not recorded · provider not recorded
- Target as extracted
- Not recorded
- Stated deadline as extracted
- None recorded
- Recorded outcome date
- Not recorded
- Outcome price observation
- Not recorded
- Not recorded · provider not recorded
Stored explanation
No explanation was recorded for this outcome.
Missing timestamps, providers and versions are historical gaps. Stored observations can include daily closes; they do not show every intraday touch or prove an executable trade. Read the methodology.
Why we interpreted the confidence this way
The strong investor-return language is explicitly conditional on sustained growth; 'going to' is offset by 'if' and 'might'.